Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Head Neck. 2018 Feb 1;40(5):1008–1015. doi: 10.1002/hed.25079

Table 2.

Table of clinico-pathological factors used in the nomogram models in the nomogram generating cohort and validation cohort.

Variable Original
Cohort
% Validation
Cohort
% P value
(χ2 test)

Grade Low/Intermediate 104 34.6 79 64.2 .006
High 110 36.5 44 35.8
NK* 87 28.9

LVI Yes 67 22.2 18 14.7 .000
No 129 42.9 103 83.7
NK* 105 34.9 2 1.6

PNI Yes 99 32.9 51 41.5 .272
No 107 35.5 71 57.7
NK* 95 31.6 1 0.8

Margin Negative 113 37.5 48 39.0 .753
Positive/close 158 52.5 72 58.5
NK* 30 10.0 3 2.5

Positive nodes Yes 72 23.9 24 19.5 .268
No 217 72.1 97 78.9
NK* 12 4.0 2 1.6

Max tumor size Mean 2.5 2.2 .004
Range (Min, Max) (1.5, 3.5) (1.5, 3.2)

Clinical T4 Yes 32 10.6 12 9.8 .789
No 269 89.4 111 90.2

LVI-Lymphovascular invasion, PNI-Perineural invasion.

*

NK = not known. These patients were not included in statistical test